Answer
Cemiplimab binds to the PD-1 receptor and blocks its interaction with the ligands PD-L1 and PD-L2.
Sources for this answer
- LIBTAYO 350 mg concentrate for solution for infusion.Regeneron UK Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 25Document updated
Sources checked